PTC Therapeutics, Inc. revenue breakdown overview

PTC Therapeutics, Inc. revenue for the last year amounted to 937.82 M USD, the most of which — 937.82 M USD — came from its highest performing source at the moment, Small Molecule and Gene Therapeutics, the year earlier bringing 698.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought PTC Therapeutics, Inc. 531.66 M USD, and the year before that — 498.57 M USD.